Navigation Links
Cold Meds Not Safe for Kids Under 2, FDA Warns
Date:1/17/2008

lth Staff, had this advice for those caring for children over the age of 2:

  • Always remember that these medications do not cure colds, they don't shorten the time the child has the cold and are only meant to help a child's symptoms.
  • If you choose to give medication, look at the active ingredients' section of the label and what symptoms each active ingredient is intended to treat.
  • Be very careful in giving more than one over-the-counter cough and cold medication to your child. Remember that many OTC cough and cold products have multiple medications in them. If you use two medications with similar active ingredients, this could hurt a child.
  • Make sure to carefully follow directions on the label.
  • Only use the dropper or cup that comes with the medicines, not household measuring devices.
  • If you have the opportunity to use cough and cold medicines with childproof safety caps, you should do so.
  • Store all medicines out of the reach of children.
  • Call your physician or pharmacist or other health provider if you have any questions regarding the use of these medications in children 2 years or older.

"We're not trying to dictate the practice of medicine. We understand that health providers on an individual basis have to make certain decisions based on the facts presented to them, but we do need to recognize that there have been reports of serious adverse events in the less-than-2 age group related to misdosing and in attempting to choose the correct product," Ganley said. "Clearly, there have been instances where more than one product was used or it was not clear to the parent as to what the ingredients are in the products."

More information

Visit the U.S. Food and Drug Administration for more on the advisory.




'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Just hours apart, 2 brothers undergo robotic prostate cancer surgery
2. CHPA Lends Support to FDAs Announcement Against Use of Oral, Over-the-Counter Cough and Cold Medicines in Children Under Two
3. One third of stunting and a quarter of deaths among under 3s in poor countries could be prevented
4. Childrens Hospital Boston Mourns the Death of Dr. Judah Folkman, World Renowned Researcher and Founder of the Field of Angiogenesis
5. Intel Co-Founder Andrew S. Grove Dedicates Portion of His Estate, Up to $40 Million, to Michael J. Fox Foundation
6. Lenny Dykstra, Founder & President of The Players Club, to Keynote the 2008 Financial Communications Forum
7. Understanding the have-knots: The role of stress in just about everything
8. Risk factors for Parkinsons disease under study
9. Scientists identify brain abnormalities underlying key element of borderline personality disorder
10. Leading National Patient Advocacy Group Commends Insurance Industrys Recognition, Focus on Growing National Problem of Uninsured and Underinsured Americans
11. Psoriasis Study Showing Increased Risk of Death Underscores Need for More Research, Group Says
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cold Meds Not Safe for Kids Under 2, FDA Warns
(Date:7/25/2014)... As reported by Wood TV 8 in the ... has seen a nearly 500-person increase in heroin related overdose ... 271 between 1999 and 2002, the toll increased to 728 ... other states, drug users in Michigan have turned to heroin ... compared the price of both substances, noting that an 80-milligram ...
(Date:7/25/2014)... 25, 2014 (HealthDay News) -- The human brain can ... dehydration, a new study finds. Although dehydration ... England have found that the brain compensates by increasing ... "This research has helped us understand a lot ... exercise in extreme conditions," study first author Steven Trangmar, ...
(Date:7/25/2014)... 25, 2014 Ticket Down is ... Milan tickets in Berkeley at California Memorial Stadium. With ... fans of football, the organizers of the 2014 Guinness International ... teams to North America. With teams representing La Liga, English ... bring some of the best football players from around the ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 This ... current state of the Galactooligosaccharides (GOS) industry ... basic overview of the industry, including definitions, applications ... Chinese domestic market analysis are provided with a ... of the market. A comparison between the international ...
(Date:7/25/2014)... Babies seem to learn even before they,re born, a ... 34 weeks pregnant, their unborn babies can respond to ... nursery rhyme, the researchers report. "The mother,s voice ... developing fetus," Charlene Krueger, nursing researcher and associate professor ... in a university news release. "This research highlights just ...
Breaking Medicine News(10 mins):Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 3Health News:Rhymes Reveal Evidence of Learning in the Womb 2
... Quigley,Corporation (Nasdaq: QGLY ) today reported net sales ... ended March 31, 2008,compared to $6.1 million reported for ... of 2008 reflects a net sales decrease for the,Company,s ... first quarter,of 2007. The change during 2008 as compared ...
... Company to Host Conference Call at 4:30 p.m. EDT Today ... PCYC ) today reported financial results for its third fiscal,quarter ... quarter of fiscal,2008 was $7.0 million, or $0.27 per share, ... share, in the third quarter of fiscal 2007., Total ...
... Actavis Group, the,international generic pharmaceuticals company, today ... study on the Company and its President,and CEO. ... was presented in an MBA class in international ... made available to business,schools around the world., ...
... Act on Capitol Hill, WASHINGTON, April 24 ... and questions for the patient, their families and,caregivers. ... cancer care by affording the patient the opportunity ... thought the cancer diagnosis, treatment,and follow up care., ...
... April 24 The Asthma and Allergy,Foundation of America ... today -- the most challenging places to live for ... year for many allergy,sufferers from Lexington, KY (ranked #1), ... Allergy Capitals based on the impact that key,environmental and ...
... Association urges Senators Boxer and Feinstein to quickly pass,companion ... April 23 AARP thanked,the supporters and cosponsors of ... passed today in the U.S. House of Representatives. The ... by stopping,harmful cuts proposed by the administration., "Today,s ...
Cached Medicine News:Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 2Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 3Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 4Health News:The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future 5Health News:Pharmacyclics Reports Third Quarter 2008 Financial Results 2Health News:Pharmacyclics Reports Third Quarter 2008 Financial Results 3Health News:Pharmacyclics Reports Third Quarter 2008 Financial Results 4Health News:Pharmacyclics Reports Third Quarter 2008 Financial Results 5Health News:Pharmacyclics Reports Third Quarter 2008 Financial Results 6Health News:Harvard Business School Publishes a Case Study on Robert Wessman and Actavis 2Health News:Harvard Business School Publishes a Case Study on Robert Wessman and Actavis 3Health News:Support for Patient Navigation Services to Help Cancer Patients 2Health News:2008 Spring Allergy Capitals Announced 2Health News:AARP Thanks California's Representatives for Supporting Bill to Protect People in Medicaid 2
(Date:7/25/2014)... , July 25, 2014  Depomed, Inc. (NASDAQ: ... second quarter fiscal year 2014 financial results after the ... host a conference call beginning at 4:30 pm EDT, 1:30 ... access the call by dialing 877-317-6789 ( United ... will also be available via a live webcast on ...
(Date:7/25/2014)... LAS VEGAS , July 25, 2014 GrowBLOX ... of a binding Memorandum of Understanding ("MOU") with LaurelCo, LLC, ... to pursue the acquisition of both cultivation and dispensary medical ... . Pursuant to the MOU, GBLX will acquire a 20% ... use our proprietary GrowBLOX TM growing chambers, as well ...
(Date:7/25/2014)... ALBANY, New York , July 25, 2014 /PRNewswire/ ... published by Transparency Market Research "Global and China Insulin ... Insulin) - Industry Analysis, Size, Share, Growth, Trends and ... insulin market was valued at USD 19.99 billion in ... of 6.1% from 2013 to 2019 to reach USD ...
Breaking Medicine Technology:Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4
... CVS Caremark Corporation (NYSE: CVS ) today announced that Tom Ryan , Chairman, President and CEO, ... to investors at the Barclays Capital 2010 Global Healthcare Conference on March 23, 2010 . The Company is ... ... , ...
... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended ... ... ... ...
Cached Medicine Technology:CVS Caremark to Present at the Barclays Capital 2010 Global Healthcare Conference 2CVS Caremark to Present at the Barclays Capital 2010 Global Healthcare Conference 3BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 5BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 6BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 7BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 9BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 10BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 11BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 12BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2009 Financial Results 13
Stainless steel dull finish....
9 mm diameter pigtail curved blunt probes. Stainless steel. Round knurled handle with polished finish. Includes pre-cut polyethylene tubes. Overall length: 5.9 inches....
12 mm diameter pigtail curved probes with eyes 4mm back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.9 inches....
The Novus 2000 argon laser combines power, size, and versatility. Ideal for the office, clinic and operating room environments, Novus 2000 is the world's most widely accepted ophthalmic laser....
Medicine Products: